Laboratoires Expanscience
Records under this name other than the patents Laboratoires Expanscience holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 52 patents it holds.
Back to Laboratoires Expanscience
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,493,303 | Solid/liquid extraction Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,236,836 | Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof Term ended Term ended Jul 25, 2026 · From the USPTO record | Term ended | Term ended Jul 25, 2026 | From the USPTO record |
| US 7,589,121 | Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight Term ended Term ended Jun 14, 2025 · From the USPTO record | Term ended | Term ended Jun 14, 2025 | From the USPTO record |
| US 7,872,043 | Use of furan alkyls for a cellulite cosmetic treatment Term ended Term ended May 27, 2025 · From the USPTO record | Term ended | Term ended May 27, 2025 | From the USPTO record |
| US 7,897,579 | Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases Term ended Term ended Apr 29, 2025 · From the USPTO record | Term ended | Term ended Apr 29, 2025 | From the USPTO record |
| US 8,349,377 | Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency Term ended Ended no later than Apr 29, 2025 · From the USPTO record | Term ended | Ended no later than Apr 29, 2025 | From the USPTO record |
| US 7,629,371 | Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite Term ended Term ended Apr 9, 2025 · From the USPTO record | Term ended | Term ended Apr 9, 2025 | From the USPTO record |
| US 7,473,434 | Maca extract and cosmetic composition containing such an extract Term ended Term ended Feb 10, 2025 · From the USPTO record | Term ended | Term ended Feb 10, 2025 | From the USPTO record |
| US 8,653,117 | Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof Term ended Term ended Apr 19, 2024 · From the USPTO record | Term ended | Term ended Apr 19, 2024 | From the USPTO record |
| US 8,318,186 | Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive Term ended Term ended Oct 14, 2023 · From the USPTO record | Term ended | Term ended Oct 14, 2023 | From the USPTO record |